There were 132 press releases posted in the last 24 hours and 429,136 in the last 365 days.

Contact

Please use this form to send email to PR contact of this press release:
InflaRx Completes Enrollment in Vilobelimab (IFX-1) European Phase II Study in ANCA-associated Vasculitis

TO:



FROM:

Please check your email address!

Please, do not fill this field.

Please, do not change this field.

Please, do not fill if your javascript is turned off.

captcha image